Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-10, Stock:JNJ, The news for the past five days is as follows:
2019-01-03: NEWS1: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS2: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS3: VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster.NEWS4: VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster.NEWS5: Johnson & Johnson (JNJ) Stock Moves -1.59%: What You Should Know.NEWS6: Buy Apple Stock Once It Hits This Level.NEWS7: Buy Apple Stock Once It Hits This Level.NEWS8: VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster.NEWS9: Why Johnson & Johnson Stock is Clearly Set to Rise Again.NEWS10: Triangle pharma inks deal with Johnson and Johnson that's potentially worth $818M.NEWS11: Buy Apple Stock Once It Hits This Level.NEWS12: Can the nose point the way to early lung cancer detection? This Peninsula company's Big Pharma deal aims to find out.NEWS13: Health Care Sector Update for 01/03/2019: CELG, BMY, KTOV, OHRP, JNJ, PFE, MRK, ABT, AMGN.NEWS14: Health Care Sector Update for 01/03/2019: CELG, BMY, KTOV, OHRP, JNJ, PFE, MRK, ABT, AMGN.NEWS15: Stocks making the biggest moves premarket: AAPL, CELG, JNJ, UBS & more.NEWS16: Dow set to sink | Apple plunges 9% | Celgene surges on buyout offer.NEWS17: Dow set to sink | Apple plunges 9% | Celgene surges on buyout offer.NEWS18: U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filing.NEWS19: U.S. drugmaker Johnson & Johnson's India sales dip 3 percent in 2017/18 - filing.
2019-01-04: NEWS1: AbbVie (ABBV) Inks Immunotherapy Deal with Private Biotech.NEWS2: Bristol To Become Top 5 Pharma — And Other Fallout From Celgene Takeover.NEWS3: 4 Dividend Stocks Youll Regret Holding in 2019.NEWS4: 4 Dividend Stocks Youll Regret Holding in 2019.NEWS5: Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS8: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS9: Pfizer Begins Pivotal Study on Alopecia Areata Candidate.NEWS10: Today's Research Reports on Trending Tickers: Johnson & Johnson and Merck & Co..NEWS11: Johnson & Johnson (JNJ) Stock Moves -1.59%: What You Should Know.NEWS12: Johnson & Johnson (JNJ) Stock Moves -1.59%: What You Should Know.
2019-01-07: NEWS1: 8 Stocks To Outperform In An Uncertain Market.NEWS2: Jon Najarian Sees Big Options Activity In Johnson & Johnson, Nvidia.NEWS3: Options traders jump into J&J and this big tech name.NEWS4: Johnson & Johnson Might Take a While to Recover With No Bottom in Sight.NEWS5: Johnson & Johnson To Present At JP Morgan Conference; Webcast At 5:30 PM ET.NEWS6: Johnson & Johnson To Present At JP Morgan Conference; Webcast At 5:30 PM ET.NEWS7: Health Care Sector Update for 01/07/2019: LOXO, LLY, MYND, AXSM, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 01/07/2019: LOXO, LLY, MYND, AXSM, JNJ, PFE, MRK, ABT, AMGN.NEWS9: 5 Things to Watch for at the JPMorgan Healthcare Conference.
2019-01-08: NEWS1: Here&apos;s What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018.NEWS2: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS3: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS4: Top Analyst Reports for Visa, Coca-Cola & AbbVie.NEWS5: Latest trial in J&J talc litigations gets under way in California.NEWS6: Albany region cities sue pharmaceutical companies over opioid epidemic.NEWS7: Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Latest trial in J&J talc litigations gets under way in California.
2019-01-09: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon.NEWS3: Karyopharm Files MAA for Myeloma Candidate Selinexor in EU.NEWS4: Karyopharm Files MAA for Myeloma Candidate Selinexor in EU.NEWS5: Why Johnson & Johnson Stock Fell 12% in December.NEWS6: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS7: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS8: Karyopharm Files MAA for Myeloma Candidate Selinexor in EU.NEWS9: The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy.NEWS10: Does Eli Lilly&apos;s $8 Billion Splurge Make Array BioPharma a Buy Now?.NEWS11: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS12: Innovation Puts Medtronic in the Lead.NEWS13: Why Johnson & Johnson May Not Have to Pay Its $4.7 Billion Court Verdict.NEWS14: Japan Approves Amgen/UCB's Osteoporosis Drug - Will U.S. Follow Suit?.NEWS15: Japan Approves Amgen/UCB's Osteoporosis Drug - Will U.S. Follow Suit?.NEWS16: Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018.NEWS17: Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018.

Answer: Rise